Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes.

作者: J. Zuckermann , L. B. Moreira , P. Stoll , L. M. Moreira , R. S. Kuchenbecker

DOI: 10.1007/S00277-007-0390-7

关键词:

摘要: Febrile neutropenia is associated with significant morbidity and mortality. Managing infectious in neutropenic patients remains a dynamic process, making necessary timely efficient empirical antibiotic therapy. The implementation of critical pathways has been suggested as strategy to improve clinical effectiveness. This study evaluated the compliance an institutional pathway for management febrile impact on outcomes at Hospital de Clinicas Porto Alegre, Brazil (HCPA). We performed cohort that prospectively included hospitalized from January 2004 December 2005 presented (190 episodes). Historical controls were selected March 2001 April 2003 (193 episodes) before was introduced. showed low rate full (21.6%; 95% CI 15.7–27.5) pathway. In most cases, there partial (67.9%; 61.3–74.5). Despite moderate adherence observed, we recorded decrease in-hospital all-cause mortality sample studied after protocol (from 24.4 14.4%; P = 0.017) reduction length use cephalosporin quinolones. conclusion, seems be effective neutropenia.

参考文章(32)
S. H Woolf, R. Grol, A. Hutchinson, M. Eccles, J. Grimshaw, Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. ,vol. 318, pp. 527- 530 ,(1999) , 10.1136/BMJ.318.7182.527
María Elena Santolaya de P, Ricardo Rabagliati B, Teresa Bidart H, Ernesto Payá G, Ana M Guzmán D, Ricardo Morales I, Stephanie Braun J, Lucía Bronfman F, Marcela Ferrés G, Claudio Flores P, Patricia García C, Luz M Letelier S, Bárbara Puga L, Carmen Salgado M, Luis Thompson M, Juan Tordecilla C, Marcela Zubieta A, Consenso Manejo racional del paciente con cáncer, neutropenia y fiebre: Rational approach towards the patient with cancer, fever and neutropenia Revista Chilena De Infectologia. ,vol. 22, pp. 79- 113 ,(2005) , 10.4067/S0716-10182005000500001
Graham Worrall, Paul Chaulk, Darren Freake, The effects of clinical practice guidelines on patient outcomes in primary care: a systematic review Canadian Medical Association Journal. ,vol. 156, pp. 1705- 1712 ,(1997)
Liat Vidal, Itsik Ben dor, Mical Paul, Noa Eliakim-Raz, Ellisheva Pokroy, Karla Soares-Weiser, Leonard Leibovici, Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients Cochrane Database of Systematic Reviews. ,vol. 2013, ,(2013) , 10.1002/14651858.CD003992.PUB3
Randall M. Zusman, James H. Chesebro, Anthony Comerota, Joseph R. Hartmann, Edward K. Massin, Eric Raps, Philip A. Wolf, Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection. Clinical Cardiology. ,vol. 22, pp. 559- 573 ,(1999) , 10.1002/CLC.4960220905
Helen Innes, Ernie Marshall, Outpatient therapy for febrile neutropenia. Current Opinion in Oncology. ,vol. 19, pp. 294- 298 ,(2007) , 10.1097/CCO.0B013E3281214436
Nikolaos V. Sipsas, Gerald P. Bodey, Dimitrios P. Kontoyiannis, Perspectives for the management of febrile neutropenic patients with cancer in the 21st century Cancer. ,vol. 103, pp. 1103- 1113 ,(2005) , 10.1002/CNCR.20890
C. Viscoli, The evolution of the empirical management of fever and neutropenia in cancer patients. Journal of Antimicrobial Chemotherapy. ,vol. 41, pp. 65- 80 ,(1998) , 10.1093/JAC/41.SUPPL_4.65